Difference between revisions of "Part:BBa K4165058"
(→Dry-Lab characterization) |
(→Dry-Lab characterization) |
||
Line 19: | Line 19: | ||
− | ===Dry-Lab | + | ===Dry-lab Characterization=== |
− | <p style=" font-weight: bold; font-size:14px;"> Modeling </p> | + | <html> |
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/38-2.jpg" style="margin-left:300px;" alt="" width="400" /></p> | ||
+ | </html> | ||
+ | Figure 1. The 3D structure of switch 38 modelled by tRrosseta. | ||
+ | |||
+ | |||
+ | |||
+ | This switch was modeled by (Alphafold - Rosettafold - tRrosetta) and the top model was obtained from tRrosseta. the pipeline for generating this model will be discussed in the next section in details | ||
+ | |||
+ | |||
+ | |||
+ | <h1>Switch construction Pipeline</h1> | ||
+ | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/registry/dry-lab-modelling-pipeline.png" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
+ | |||
+ | |||
+ | Figure 2. A figure which dsecribes our Dry-Lab Modelling Pipeline. By team CU_Egypt 2022. | ||
+ | |||
+ | <html> | ||
+ | <p style=" font-weight: bold; font-size:14px;"> 1) Modelling </p> | ||
+ | <p> Since our parts do not have experimentally acquired structures, we have to model them. This approach is done using both denovo modelling (ab initio) and template-based modelling. For modelling small peptides of our system, we used AppTest and Alphafold.</p> | ||
+ | <p style=" font-weight: bold; font-size:14px;"> 2) Structure Assessment </p> | ||
+ | <p>In order to assess the quality of our structures we used the Swiss-Model tool which gives an overall on quality of any 3D structure (For more information: <a href="https://2022.igem.wiki/cu-egypt/ProteinModelling.html"> Modelling</a>.</p> | ||
+ | <p style=" font-weight: bold; font-size:14px;"> 3) Quality Assessment </p> | ||
+ | |||
+ | <p>Using the code created by us (CU_Egypt 2022), we use the JSON files created from the structure assessment step in Swiss-Model to rank all the models For more information: <a href="https://2022.igem.wiki/cu-egypt/software.html"> Software</a> under the name of Modric.</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">4) Filtering</p> | ||
+ | <p>We take the top ranked models from the previous steps.</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">5) Docking</p> | ||
+ | <p>The top models of inhibitor and HTRA Binding Peptide are docked with HtrA1 (BBa_K4165004).</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">6) Ranking</p> | ||
+ | <p>The docking results are ranked according to their PRODIGY results. For more information: <a href="https://2022.igem.wiki/cu-egypt/Docking.html"> Docking</a>.</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">7) Top Models</p> | ||
+ | <p>The results that came out from PRODIGY are ranked and top models are chosen to proceed with to the next step. For more information: <a href="https://2022.igem.wiki/cu-egypt/Docking.html"> Docking</a>.</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">8) Alignment</p> | ||
+ | <p>Docked structures are aligned. This means that the HtrA1- binding peptide complex is aligned with the second complex which is the HtrA1-inhibitor complex to check whether they binded to the same site or not.</p> | ||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/switches/switch31/picture10.png" style="margin-left:300px;" alt="" width="300" /></p> | ||
+ | </html> | ||
+ | |||
+ | |||
+ | Figure 3. Aligned structures of HtrA1 binding peptide 1 docked to HtrA1 and inhibitor docked to HtrA1. | ||
+ | <p style=" font-weight: bold; font-size:14px;">9) Linker length</p> | ||
+ | <p>The linker lengths are acquired by seeing the distance between the inhibitor and the HtrA1 binding peptide which is between both C terminals, N terminals, C- and N- terminal, and N- and C-terminals. The distance was measured to be between 13 and 25 angstrom</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">10) Assembly</p> | ||
+ | <p>After settling on the linkers lengths, now we will proceed to the assembly step of the whole system which is done using TRrosetta, AlphaFold, RosettaFold, and Modeller.</p> | ||
+ | <html> | ||
+ | <p>a<img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/switches/switch31/ninhiibitor31-clamp.png" style="margin-left:50px;" alt="" width="150" />b<img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/htra1-bp/h1b.jpg" style="margin-left:50px;" alt="" width="150" />c<img src="https://static.igem.wiki/teams/4165/wiki/q8iub5-trrosetta-model3.png" style="margin-left:50px;" alt="" width="150" /></p> | ||
+ | </html> | ||
+ | |||
+ | Figure 4. a) Seed_GGSGGGGG_seed clamp b) HTRA Binding Peptide 1 c)WAP-four disulfide core domain 13 serine protease inhibitor. | ||
+ | <html> | ||
+ | <p style=" font-weight: bold; font-size:14px;">11) Structure Assessment</p> | ||
+ | <p>In order to assess the quality of our structures we used the Swiss-Model tool which gives an overall on quality of any 3D structure (For more information: <a href="https://2022.igem.wiki/cu-egypt/ProteinModelling.html"> Modeling</a>.</p> | ||
+ | |||
+ | <p style=" font-weight: bold; font-size:14px;">12) Quality Assessment </p> | ||
+ | <p>Using the code created by us (CU_Egypt 2022), we use the JSON files created from the structure assessment step in Swiss-Model to rank all the models For more information: <a href="https://2022.igem.wiki/cu-egypt/software.html"> Software</a> under the name of Modric.</p> | ||
+ | |||
− | + | <p style=" font-weight: bold; font-size:14px;">13) Ranking</p> | |
+ | <p>Using the code created by us (CU_Egypt 2022), we use the JSON files created from the structure assessment step in Swiss-Model to rank all the models For more information: <a href="https://2022.igem.wiki/cu-egypt/software.html"> Software</a> under the name of Abu Trika.</p> | ||
+ | <p style=" font-weight: bold; font-size:14px;">Table 1. quality assessment parameters of switch 32.</p> | ||
<html> | <html> | ||
<style> | <style> | ||
Line 53: | Line 120: | ||
</body> | </body> | ||
</html> | </html> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===Refernces=== | ===Refernces=== |
Revision as of 23:25, 13 October 2022
HtrA1 Switch 38
This composite part consists of T7 promoter (BBa_K3633015), lac operator (BBa_K4165062), pGS-21a RBS (BBa_K4165016), 6x His-tag (BBa_K4165020), H1A (BBa_K4165000), GS Linker (BBa_K4165068), seed peptide (BBa_K4165012), GS Linker (BBa_K4165019), seed peptide (BBa_K4165012), GS Linker (BBa_K4165068), WAP inhibitor (BBa_K4165008), and T7 terminator (BBa_K731721).
Usage and Biology
Switch 38 is used to mediate the activity of HTRA1. It is composed of 3 parts connected by different linkers; an HtrA1 PDZ peptide, a clamp of two targeting peptides for tau or amyloid beta, and a catalytic domain inhibitor. Activating HTRA1 requires a conformational change in the linker, eliminating the attached inhibitor from the active site. The conformational rearrangement can be mediated through the binding of affinity clamp to tau or beta-amyloid. This binding will result in a tension that detaches the inhibitor from the active site.
The seed peptide which is considered as an amyloid binding peptide is proved experimentally to inhibit the aggregations of amyloid beta through cell viability assays with a survival rate values nearly 100%. The H1A peptide was also proven to bind with the PDZ of HtrA1 experimentally. The last part which is the inhibitor which is mainly a serine protease inhibitor, and since our protease is a serine protease, so it will act and inhibit the Protein. The whole construction was similarly proved from literature.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 589
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 572
Illegal AgeI site found at 308 - 1000COMPATIBLE WITH RFC[1000]
Dry-lab Characterization
Figure 1. The 3D structure of switch 38 modelled by tRrosseta.
This switch was modeled by (Alphafold - Rosettafold - tRrosetta) and the top model was obtained from tRrosseta. the pipeline for generating this model will be discussed in the next section in details
Switch construction Pipeline
Figure 2. A figure which dsecribes our Dry-Lab Modelling Pipeline. By team CU_Egypt 2022.
1) Modelling
Since our parts do not have experimentally acquired structures, we have to model them. This approach is done using both denovo modelling (ab initio) and template-based modelling. For modelling small peptides of our system, we used AppTest and Alphafold.
2) Structure Assessment
In order to assess the quality of our structures we used the Swiss-Model tool which gives an overall on quality of any 3D structure (For more information: Modelling.
3) Quality Assessment
Using the code created by us (CU_Egypt 2022), we use the JSON files created from the structure assessment step in Swiss-Model to rank all the models For more information: Software under the name of Modric.
4) Filtering
We take the top ranked models from the previous steps.
5) Docking
The top models of inhibitor and HTRA Binding Peptide are docked with HtrA1 (BBa_K4165004).
6) Ranking
The docking results are ranked according to their PRODIGY results. For more information: Docking.
7) Top Models
The results that came out from PRODIGY are ranked and top models are chosen to proceed with to the next step. For more information: Docking.
8) Alignment
Docked structures are aligned. This means that the HtrA1- binding peptide complex is aligned with the second complex which is the HtrA1-inhibitor complex to check whether they binded to the same site or not.
Figure 3. Aligned structures of HtrA1 binding peptide 1 docked to HtrA1 and inhibitor docked to HtrA1.
9) Linker length
The linker lengths are acquired by seeing the distance between the inhibitor and the HtrA1 binding peptide which is between both C terminals, N terminals, C- and N- terminal, and N- and C-terminals. The distance was measured to be between 13 and 25 angstrom
10) Assembly
After settling on the linkers lengths, now we will proceed to the assembly step of the whole system which is done using TRrosetta, AlphaFold, RosettaFold, and Modeller.
abc
Figure 4. a) Seed_GGSGGGGG_seed clamp b) HTRA Binding Peptide 1 c)WAP-four disulfide core domain 13 serine protease inhibitor.
11) Structure Assessment
In order to assess the quality of our structures we used the Swiss-Model tool which gives an overall on quality of any 3D structure (For more information: Modeling.
12) Quality Assessment
Using the code created by us (CU_Egypt 2022), we use the JSON files created from the structure assessment step in Swiss-Model to rank all the models For more information: Software under the name of Modric.
13) Ranking
Using the code created by us (CU_Egypt 2022), we use the JSON files created from the structure assessment step in Swiss-Model to rank all the models For more information: Software under the name of Abu Trika.
Table 1. quality assessment parameters of switch 32.
cbeta_deviations | clashscore | molprobity | ramachandran_favored | ramachandran_outliers | Qmean_4 | Qmean_6 |
---|---|---|---|---|---|---|
0 | 154.75 | 2.65 | 98.44 | 0 | -1.38724 | -2.76799 |
Refernces
1. Lu, J., Cao, Q., Wang, C., Zheng, J., Luo, F., Xie, J., ... & Li, D. (2019). Structure-based peptide inhibitor design of amyloid-β aggregation. Frontiers in molecular neuroscience, 12, 54. 2. Romero-Molina, S., Ruiz-Blanco, Y. B., Mieres-Perez, J., Harms, M., Münch, J., Ehrmann, M., & Sanchez-Garcia, E. (2022). PPI-Affinity: A Web Tool for the Prediction and Optimization of Protein–Peptide and Protein–Protein Binding Affinity. Journal of Proteome Research. 3. Stein, V., & Alexandrov, K. (2014). Protease-based synthetic sensing and signal amplification. Proceedings of the National Academy of Sciences, 111(45), 15934-15939